中芯國際(00981.HK):美場外交易獲延長 今起恢復買賣
中芯國際(00981.HK)公布,有關美國人士被限制對公司所發行的有價證券及其相關的衍生品進行交易、美國總統於今年11月12日發布的行政命令及從OTCQX撤出,於1月9日公司獲OTCQX市場的營運者OTC Markets Group通知,其監管機構通知OTC Markets Group,其已改變了有關行政命令生效日期的立場,現在允許公司的證券交易持續到今年 2月1日。因此,OTC Markets Group已取消了其待刪除SMICY和SIUIF的程序,並計劃在今年1月11日開市之前在OTCQX上恢復SMICY和SIUIF的交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.